PD Monika Pizon is Head of Research at Spezielle Immunologie Forschung + Entwicklung GmbH (simfo), Bayreuth, Germany since 2023, where she previously worked as Senior Scientist (2010–2023). She began her academic career as a Research Assistant at the Jagiellonian University, Krakow, Poland and as a Medical Laboratory Scientist in Pediatric Hematology and Oncology. She holds an MSc in Medical Analytics (2001) and a PhD in Medical Sciences (2005) from Jagiellonian University, Krakow, Poland and completed her Habilitation in 2023 at the Silesian Medical University, Katowice, Poland with a thesis on circulating tumor cell subpopulations in breast cancer. Her research focuses on the characterization of circulating epithelial tumor cells (CETCs) and cancer stem cells as biomarkers for metastasis, therapy resistance, and personalized treatment strategies. She has published over 20 peer-reviewed articles in leading journals such as Oncotarget, PLoS ONE, International Journal of Oncology, Scientific Reports, and Cancers, and contributed to numerous international conferences. PD Pizon is a member of the American Association for Cancer Research (AACR). Her work has been recognized for advancing the understanding of tumor cell heterogeneity, immune evasion, and translational oncology models, including the use of patient-derived xenografts from circulating cancer stem cells.